Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Marginal zone B and B1 cell-specific protein (MZB1)
- Target
- MZB1
- Molecular classification
- Other (secreted protein, cytokine/adipokine role reported), not a receptor, enzyme, transporter, ion channel, transcription factor
01
Overview
Marginal zone B and B1 cell-specific protein (MZB1) is a secreted protein primarily expressed in marginal zone B cells and B1 B lymphocytes, encoded by the MZB1 gene on human chromosome 5[1][2]. MZB1 functions in immune regulation, particularly in antibody-secreting cells and plasma cell differentiation, and plays roles as a pro-inflammatory cytokine and possibly a hormone-regulated adipokine, influencing chronic inflammation and cellular expansion[3][7]. MZB1 is under investigation as a potential therapeutic target in conditions marked by pathogenic antibody production or chronic inflammation, but no drugs are approved or in advanced clinical trials specifically targeting MZB1[3][7].
- Other names
- MZB1MEDA-7PACAPpERp1HSPC190MGC29506PERP1
02
Mechanism of action
No specific drug mechanisms established; research suggests targeting MZB1 reduces excessive antibody-secreting cell activity
03
Biological functions
Immune responseRegulation of antibody-secreting cellsPro-inflammatory cytokine activityPotential hormone-regulated adipokineCellular expansionProtein folding (specifically in B cells)
04
Disease associations
InflammationAutoimmune diseasePossible roles in excessive antibody production (e.g., autoimmune conditions)Chronic inflammationPotential involvement in cancer and bone loss (literature-based but less directly established)
05
Safety considerations
No major therapeutic safety concerns established in the literatureAs it regulates adaptive immunity, targeting may disrupt antibody production and normal immune function
06
Biomarkers
Not directly established; possible biomarker for excessive antibody-secreting cell populations or inflammatory status
Beyond the preview
Go deeper on Marginal zone B and B1 cell-specific protein (MZB1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Marginal zone B and B1 cell-specific protein (MZB1).